Literature DB >> 21554201

Molecular mechanism of liver cancer.

Hongming Pan1, Xianghui Fu, Wendong Huang.   

Abstract

Liver cancer, hepatocellular carcinoma (HCC) in particular, is one of the most deadly cancers worldwide, and the incidence of HCC is increasing rapidly in the United States and other developed countries. Epidemiological studies have identified major risk factors for HCC, including infection with hepatitis B and C virus (HBV and HCV), exposure to certain chemicals, high intake of alcohol, as well as metabolic diseases such as obesity and diabetes that are rapidly rising in the US. Although the etiologies for liver carcinogenesis are relatively well defined, the exact mechanism and pathways leading to cancer development are still unclear. Chronic liver injury, followed by inflammation and irregular liver regeneration has been suggested as an important step in hepatocarcinogenesis. Therefore, the identification of key factors that protect the liver from injury and inflammation could provide valuable insight into the development of HCC. In this review, we will summarize the recent findings in HCC studies, mainly focusing on the new molecular link among inflammation, liver repair and HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554201     DOI: 10.2174/187152011796011073

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  15 in total

1.  Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.

Authors:  Yong-Shuang Li; Qiang Xie; Da-Ye Yang; Yuan Zheng
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

2.  Prognostic significance of SOX-1 expression in human hepatocelluar cancer.

Authors:  Jinshu Lou; Kai Zhang; Jing Chen; Yanping Gao; Rui Wang; Long-Bang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult.

Authors:  Mutsumi Tsuchishima; Joseph George; Hisakazu Shiroeda; Tomiyasu Arisawa; Tsutomu Takegami; Mikihiro Tsutsumi
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

4.  The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.

Authors:  Shi-Yun Cui; Jia-Yuan Huang; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Wei De; Rui Wang; Long-Bang Chen
Journal:  Cell Cycle       Date:  2013-08-07       Impact factor: 4.534

Review 5.  Bile acid signaling and liver regeneration.

Authors:  Mingjie Fan; Xichun Wang; Ganyu Xu; Qingfeng Yan; Wendong Huang
Journal:  Biochim Biophys Acta       Date:  2014-05-27

6.  ARA lncRNA, is upregulated in liver and breast tumor tissues.

Authors:  Farzaneh Raeisi; Mahdieh Abolfathi; Raheleh Ahmadi-Naji; Sara Iranparast; Esmat Noshadi; Arvand Akbari; Esmaeil Mahmoudi; Mansoor Khaledi; Asghar Arshi
Journal:  Mol Biol Rep       Date:  2018-10-26       Impact factor: 2.316

7.  Trichloroethylene-induced gene expression and DNA methylation changes in B6C3F1 mouse liver.

Authors:  Yan Jiang; Jiahong Chen; Jian Tong; Tao Chen
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

8.  Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma.

Authors:  Xinyuan Zhang; Jie Sheng; Yuhong Zhang; Yu Tian; Jie Zhu; Nan Luo; Congshu Xiao; Rongkuan Li
Journal:  Oncotarget       Date:  2017-11-27

9.  KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells.

Authors:  Zheng Chen; Xiangling Wang; Ruiyan Liu; Lin Chen; Jianying Yi; Bing Qi; Zeyu Shuang; Min Liu; Xin Li; Shengping Li; Hua Tang
Journal:  Oncotarget       Date:  2017-03-14

10.  Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.

Authors:  Huidong Sun; Yanchao Gao; Kemei Lu; Guimei Zhao; Xuehua Li; Zhu Li; Hong Chang
Journal:  World J Surg Oncol       Date:  2015-10-24       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.